Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brown Advisory Small-Cap Growth Fund Institutional Shares (BAFSX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to achieve capital appreciation by primarily investing in equity securities. The fund normally invests at least 80% of its net assets (plus borrowings for investment purposes) in equity securities of small domestic companies. Small companies, according to the Adviser, are companies whose market capitalizations are generally less than $6 billion at the time of purchase. It invests primarily in companies the Adviser believes have above average growth prospects.


1 month-2.32% 3 years+7.67%
3 months+1.58% 5 years+14.35%
1 year+13.22% Since inception+12.07%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+14.35%+14.42%
Expense ratio0.99%1.33%
Risk 5 year sharpe ratio1.220.95
Net assets$373.9M$876.8M
Average market cap$2.9B$3.0B
Average P/E34.625.9
Portfolio turnover32%32%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyBrown Advisory Funds
Fund manager & tenureChristopher Berrier / 10 Years
Minimal initial investment$1,000,000.00
Minimum IRA investment--


U.S. stock86.74%
International stock1.95%
Fixed income0.75%
Top 5 Sectors
Portfolio weighting
Healthcare 22.48%
Consumer service 15.70%
Industrial materials 11.57%
Business service 10.14%
Energy 8.78%
Top 10 Holdings
Portfolio weighting
-- 4.05%
CCOI Cogent Communications Holdings Inc3.11%
BSFT BroadSoft Inc3.02%
BFAM Bright Horizons Family Solutions Inc2.42%
LTRPA Liberty Tripadvisor Holdings Inc2.39%
BR Broadridge Financial Solutions Inc2.27%
ININ Interactive Intelligence Group Inc2.24%
CRL Charles River Laboratories International Inc2.23%
CAVM Cavium Inc2.20%
IDXX IDEXX Laboratories Inc2.13%